Current Perspectives of Anticoagulation in Patients With COVID-19

被引：17

作者：

Gavioli, Elizabeth M. ^{[1
]}

Sikorska, Gabriela ^{[1
]}

Man, Ammy ^{[1
]}

Rana, Jay ^{[1
]}

Vider, Etty ^{[1
,2
]}

机构：

[1] Arnold & Marie Schwartz Coll Pharm & Hlth Sci, Div Pharm, Brooklyn, NY USA

[2] Brookdale Hosp, Med Ctr, Div Pharm, Brooklyn, NY USA

来源：

JOURNAL OF CARDIOVASCULAR PHARMACOLOGY | 2020年 / 76卷 / 02期

关键词：

SARS-CoV-2; COVID-19; thromboembolism; anticoagulation; MANAGEMENT; DISEASE;

D O I：

10.1097/FJC.0000000000000861

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Thromboembolism and myocardial injury is common in patients with COVID-19. Low-molecular-weight heparin appears to be associated with a good prognosis in patients with COVID-19 and has the ability to reduce coagulation and inflammation markers. Hospitalized patients with COVID-19 should be placed on thromboprophylaxis with the option of full therapeutic anticoagulation or tissue plasminogen activator in high-risk or mechanically ventilated patients. Thromboprophylaxis should also be considered at hospital discharge for high-risk patients. Clinical judgment should be used to evaluate the bleeding and safety risk of anticoagulation in patients with COVID-19 without confirmed data.

引用

页码：146 / 150

页数：5

共 50 条

[1] Anticoagulation in patients with COVID-19
Pekrul, I.
Spannagl, M.
Nitschmann, S.
INTERNIST, 2021, 62 (11): : 1253 - 1255
[2] Anticoagulation in COVID-19: current concepts and controversies
Chandra, Atanu
Chakraborty, Uddalak
Ghosh, Shrestha
Dasgupta, Sugata
POSTGRADUATE MEDICAL JOURNAL, 2022, 98 (1159) : 395 - 402
[3] Therapeutic anticoagulation in COVID-19 patients
Belfaqeeh, O.
Patel, J.
Janapala, R. N.
Pourmand, A.
THROMBOSIS RESEARCH, 2021, 208 : 213 - 213
[4] Therapeutic anticoagulation in COVID-19 patients
Lemos, Anna Cristina Bertoldi
Santo, Douglas Alexandre do Espirito
Miranda, Carlos Henrique
THROMBOSIS RESEARCH, 2021, 203 : 72 - 73
[5] Anticoagulation in Hospitalized Patients with Covid-19
Chowdhury, Jehan F.
Moores, Lisa K.
Connors, Jean M.
NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (17): : 1675 - 1678
[6] Anticoagulation in hospitalized patients with COVID-19
Kreuziger, Lisa Baumann
Sholzberg, Michelle
Cushman, Mary
BLOOD, 2022, 140 (08) : 809 - 814
[7] Role of Therapeutic Anticoagulation in COVID-19: The Current Situation
Rahi, Mandeep Singh
Parekh, Jay
Pednekar, Prachi
Mudgal, Mayuri
Jindal, Vishal
Gunasekaran, Kulothungan
HEMATOLOGY REPORTS, 2023, 15 (02) : 358 - 369
[8] COVID-19 Coagulopathy: Current knowledge and guidelines on anticoagulation
Salabei, Joshua K.
Fishman, Troy J.
Asnake, Zekarias T.
Ali, Arroj
Iyer, Uma G.
HEART & LUNG, 2021, 50 (02): : 357 - 360
[9] Assessing Current Therapeutic Anticoagulation Strategies In Severely Obese Patients With Covid-19
You, Joseph
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2022, 42
[10] COVID-19: The Patients' Perspectives
White, David
Gee, Patrick O.
Temple, Trace
TRANSPLANTATION, 2021, 105 (01) : 4 - 5

← 1 2 3 4 5 →